Results 311 to 320 of about 1,882,229 (349)

Landscape of the Epstein-Barr virus-host chromatin interactome and gene regulation. [PDF]

EMBO J
Tian SZ, Yang Y, Ning D, Yu T, Gao T, Deng Y, Fang K, Xu Y, Jing K, Huang G, Chen G, Yin P, Li Y, Zeng F, Tian R, Zheng M.   +15 more
europepmc   +1 more source

Screening of Theaflavins That Inhibit Proliferation of Nasopharyngeal Carcinoma Cells Through Metabolomics Approaches

Food Science &Nutrition, Volume 13, Issue 8, August 2025.
This study investigated the effects of theaflavin‐3,3′‐digallate (TF3) markedly suppresses the proliferation, migration, invasion of nasopharyngeal carcinoma cells while promoting apoptosis in a dose‐dependent manner. Metabolomic profiling identified 584 altered metabolites, revealing key disruptions in ABC transporter activity and amino acid ...
Chunpeng Wan, Xiaomeng Hu, Puxiang Yang, Mingxi Li, Muhammad Farrukh Nisar, Zihao Zhou, Yudi Gan, Yi Cai, Zhonghua Liu   +8 more
wiley   +1 more source

Oral ulcer in systemic lupus erythematosus: a case of methotrexate-induced Epstein-Barr virus infection. [PDF]

Rheumatol Adv Pract
Malik N, Malik M, Guan S, Haque S, Porter R.   +4 more
europepmc   +1 more source

Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials

Food Science &Nutrition, Volume 13, Issue 8, August 2025.
Epigallocatechin gallate (EGCG), a bioactive compound abundantly exists in green tea and grapes with strong antioxidant activity and anticancer potential is a suitable approach to reduce the cancer burden. The invitro and invivo anticancer studies of EGCG proved anticancer and anti‐tumor effect through modulation of cancer signaling pathways, reduction
Ahmad Mujtaba Noman, Muhammad Tauseef Sultan, Aimen Mazhar, Iqra Baig, Jawaria Javaid, Muzzamal Hussain, Muhammad Imran, Suliman A. Alsagaby, Waleed Al Abdulmonem, Ahmed Mujtaba, Tadesse Fenta Yehuala, Mohammed M. Ghoneim, Ehab M. Mostafa, Mohamed A. Abdelgawad   +13 more
wiley   +1 more source

A Comparative Genomic Analysis of Epstein-Barr Virus Strains with a Focus on EBV2 Variability. [PDF]

Int J Mol Sci
Blazquez AC, Fellner MD, Lorenzetti MA, Preciado MV.   +3 more
europepmc   +1 more source

Development of Broadly Applicable Reference EVs Expressing Horseradish Peroxidase

Journal of Extracellular Vesicles, Volume 14, Issue 8, August 2025.
ABSTRACT Extracellular vesicles (EVs) hold great promise as circulating biomarkers for diagnostic and therapeutic approaches. Thus, many research groups world‐wide investigate important aspects of EVs including their biology and medical significance. For this, a large number of procedures and protocols has been established making it difficult to almost
Daniela Waas, Marc Juraschitz, Yen‐Fu Adam Chen, Harald Waltenberger, Wolfgang Hammerschmidt, Reinhard Zeidler, Sonja Molinaro, Kathrin Gärtner   +7 more
wiley   +1 more source

Biomarkers of pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis through single-cell transcriptomics. [PDF]

Nat Commun
Shen J, He Y, Zheng H, Xiao J, Li F, Chen K, Guo B, He Y, Liu L, Lin Z, Wang D, Liu L, Wang S, Zhou W, Zhang Y, Wei J, Wang Y, Hu R, Tang D, Wang D, Yang M.   +20 more
europepmc   +1 more source

Acquired aberrant partial CD3 expression in recurrent Epstein-Barr virus-negative solitary plasmacytoma of tonsil. [PDF]

J Pathol Transl Med
Niu C, Ren D, Tran T, Gamayo A, Rezk S, Zhao X.   +5 more
europepmc   +1 more source

Real‐World Use of Rituximab in the Treatment of Cold Agglutinin Disease in the United States: A Retrospective Study

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Introduction Rituximab is used off‐label for treating cold agglutinin disease (CAD) in the United States; however, real‐world data on its use are limited. Methods This study examined (1) treatment patterns, (2) prespecified safety outcomes, and (3) changes in hemolytic markers post rituximab infusion (threshold change from baseline: hemoglobin
Caroline Piatek, Irina Murakhovskaya, Alia Karaouni, Gandarvaka Miles, Sylvie Bozzi, Carrie Heller, Jacqueline Lucia, Reena Patel, Brad Ward, Ronnie Yoo, Morie Gertz   +10 more
wiley   +1 more source

Effects of venetoclax, a BCL2 inhibitor, in systemic chronic active Epstein-Barr virus disease. [PDF]

Sci Rep
Ohashi A, Nishio M, Yoshimori M, Koike K, Kurata M, Tamai H, Imadome KI, Arai A.   +7 more
europepmc   +1 more source